1007-3418
2011 Issue 11
..............page:867,872
Study on dysmetabolism in patients with non-alcoholic fatty liver disease and its different combinations
LIANG Jing;CHU Yu-shun;HAN Tao;LI Yan;JIANG Yan-ying
LIANG Jing;CHU Yu-shun;HAN Tao;LI Yan;JIANG Yan-ying
..............page:865-867
Comments on the domestically provided hepatitis C core antigent ELISA reagent
WANG Jia-an;TIAN Yu-feng
WANG Jia-an;TIAN Yu-feng
..............page:863-864
A five-year follow-up of one hundred and thirty-six patients of hepatitis C
SHE Lan-hui;LlN Chao-shuang;CAI Qing-xian;ZHANG Xiao-hong;WU Yuan-kai;ZHAO Zhi-xin;GAO Zhi-liang
SHE Lan-hui;LlN Chao-shuang;CAI Qing-xian;ZHANG Xiao-hong;WU Yuan-kai;ZHAO Zhi-xin;GAO Zhi-liang
..............page:823-827
Effects of exogenous TGF-β3 on the expression of endogenous TGF-β3 in hepatic stellate cell-T6 (HSC-T6)
LI Ying;DENGL Liang;QIAN Wei;ZHOU Jian-ning;XU Ke-shu
LI Ying;DENGL Liang;QIAN Wei;ZHOU Jian-ning;XU Ke-shu
..............page:843-847
The clinical importance of HBsAg quantitation in chronic hepatitis B patients
ZHANG Ji-ming;WANG Jin-yu
ZHANG Ji-ming;WANG Jin-yu
..............page:803-805
Comparison among the methods for quantitative detection of HBV serological markers and the application
WANG Yu-ming;ZHOU Ji-jun;CHENG Lin
WANG Yu-ming;ZHOU Ji-jun;CHENG Lin
..............page:812-814
Abstract efficacy of combined vaccine for the prevention of HBV transmission in highly viremic HBeAg+ mothers and the HBV markers\' dynamic change of babies in follow-up
JIANG Hong-xiu;HAN Guo-rong;WANG Cui-min;YUE Xin;WANG Gen-ju
JIANG Hong-xiu;HAN Guo-rong;WANG Cui-min;YUE Xin;WANG Gen-ju
..............page:818-822
HBx gene down-regulates miR-192 expression and inhibits apoptosis of human hepatoma cell line HepG2
XIE Qiong-hui;HE Xing-xing;CHANG Ying;JIANG Xiang;LIN Ju-sheng
XIE Qiong-hui;HE Xing-xing;CHANG Ying;JIANG Xiang;LIN Ju-sheng
..............page:857-860
Entecavir 1.0mg monotherapy or entecavir plus adefovir dipivoxil for patients with lamivudine-resistant chronic hepatitis B had suboptimal response to lamivudine plus adefovir dipivoxil
XING Jing;HAN Tao;LIU Lei;LI Ying;LI Jun;LI Yan;XIAO Shi-xiang
XING Jing;HAN Tao;LIU Lei;LI Ying;LI Jun;LI Yan;XIAO Shi-xiang
..............page:828-832
Research progress on hepatitis C virus entry receptors
CHENG Min;YANG Wei
CHENG Min;YANG Wei
..............page:877-880
Study of drug-resistant spontaneous mutation in hepatitis B virus gene
LOU Hong-mei;ZHONG Xi-tao;LI Zhi-guo;LI Qing-wang;HU Zhu;YIN Lin-feng
LOU Hong-mei;ZHONG Xi-tao;LI Zhi-guo;LI Qing-wang;HU Zhu;YIN Lin-feng
..............page:868-869
Quantitative determination for HBeAg: in clinical practice and potential future applications
WEI Lai;YANG Rui-feng
WEI Lai;YANG Rui-feng
..............page:806-808
Expressions of breast cancer metastasis suppressor-1 and heparanase in primary hepatocellular carrinoma and chronic liver diseases and the clinicopathological significances
ZENG Xiao-bo;YANG Zhu-lin
ZENG Xiao-bo;YANG Zhu-lin
..............page:870-872
Dynamic expression of tropomyosinl in rat model of hepatic fibrosis and hepatic stellate cells
LIU Jun;WANG Chun-ying;CHEN Yong-ping;LIN Zhu;YANG Tao;LU Xiao-ju
LIU Jun;WANG Chun-ying;CHEN Yong-ping;LIN Zhu;YANG Tao;LU Xiao-ju
..............page:848-852
Efficancy and safty of telbivudine in pregnanat chronic hepatitis B patients
ZHOU Yue-jin;ZHENG Jin-li;PAN Hua-jiang;JIANG Shan
ZHOU Yue-jin;ZHENG Jin-li;PAN Hua-jiang;JIANG Shan
..............page:861-862
..............page:801-802
KCTD9, a novel potassium channel related gene, was highly expressed in hepatic NK cells and T cells of fulminant hepatitis mice induced by MHV-3
ZHOU Yao-Yong;ZOU Yong;CHEN Tao;WANG Hong-wu;HAN Mei-fang;PI Bin;YAN Wei-ming;XI Dong;HUANG Jia-quan;LUO Xiao-ping;NING Qin
ZHOU Yao-Yong;ZOU Yong;CHEN Tao;WANG Hong-wu;HAN Mei-fang;PI Bin;YAN Wei-ming;XI Dong;HUANG Jia-quan;LUO Xiao-ping;NING Qin
..............page:833-837
Toll-like receptor dependent innate immune responses by primary mouse hepatocytes and its control of HBV replication
WU Jun;CHEN Ming-fa;XIA You-chen;GUO Yan;LIN Yong;SUN Chan;ZHANG Chun-yan;CHEN Yan;LIU Shen-pei;HAO You-hua;LU Meng-ji;J(o)rg F. Schlaak;YANG Dong-liang
WU Jun;CHEN Ming-fa;XIA You-chen;GUO Yan;LIN Yong;SUN Chan;ZHANG Chun-yan;CHEN Yan;LIU Shen-pei;HAO You-hua;LU Meng-ji;J(o)rg F. Schlaak;YANG Dong-liang
..............page:838-842
Detection of hepatitis B virus covalently closed circular DNA: clinical application
ZHAO Ke-kai;MLAO Xiao-hui
ZHAO Ke-kai;MLAO Xiao-hui
..............page:809-811
Progress of the diagnosis and treatment for immunoglobulin G4 associated cholangitis
TIAN Li-yan;LU Lun-gen
TIAN Li-yan;LU Lun-gen
..............page:873-876
Quantitative analyses of intrahepatic HBV cccDNA and serum HBsAg in 54 patients with chronic hepatitis B
LI Wei-jie;LI Bo-an;ZHAO Jing-min;HAN Jia-qi;LIU Yah;JIANG Ling;MAO Yuan-li;LU Feng-min;XU Dong-ping
LI Wei-jie;LI Bo-an;ZHAO Jing-min;HAN Jia-qi;LIU Yah;JIANG Ling;MAO Yuan-li;LU Feng-min;XU Dong-ping
..............page:815-817
Effect of let-7c on the proliferation of human hepatocellular carcinoma cell HCCLM3
GONG Fang-xiao;XIA Jing-lin;YANG Bi-wei;XU Xiao-jing;WU Wei-zhong
GONG Fang-xiao;XIA Jing-lin;YANG Bi-wei;XU Xiao-jing;WU Wei-zhong
..............page:853-856